John Mandrola, MD tees up a podcast on five big ACC26 trials and warns details matter, while Davide Capodanno highlights how left main PCI vs CABG evidence has matured from 1-year to 10-year meta-analyses.
Five big trials from #ACC26
Details matter, lest you be bamboozled
my first JACC paper was a meta-analysis
now, just days ago, the same journal publishes a meta-analysis of the same trials with 10-year follow-up
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare